Connor, Clark & Lunn Investment Management Ltd. Iradimed Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $28.9 Billion
- Q3 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Iradimed Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 5,982 shares of IRMD stock, worth $504,581. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,982
Previous 12,179
50.88%
Holding current value
$504,581
Previous $728,000
41.62%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding IRMD
# of Institutions
191Shares Held
6.75MCall Options Held
0Put Options Held
9.5K-
Black Rock Inc. New York, NY818KShares$69 Million0.0% of portfolio
-
Nine Ten Capital Management LLC Evanston, IL771KShares$65.1 Million14.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA567KShares$47.8 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny489KShares$41.2 Million0.05% of portfolio
-
Copeland Capital Management, LLC434KShares$36.6 Million0.66% of portfolio
About IRADIMED CORP
- Ticker IRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 12,565,100
- Market Cap $1.06B
- Description
- IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...